In Pilot Study, Electric Therapy Improves Memory
Sending low-intensity, gamma frequency electric current through the brain boosted short-term memory, perhaps by increasing cholinergic transmission.
Sending low-intensity, gamma frequency electric current through the brain boosted short-term memory, perhaps by increasing cholinergic transmission.
Herpes infection upped risk in ApoE4 carriers, damaged brain tissue, and correlated with neurodegeneration markers in the CSF.
Disruption of the membraneless organelles may explain toxicity of tau aggregates.
In cell culture, neurons with the strongest expression of cell-cycle proteins survived best in the presence of Aβ oligomers.
In early stage trials, light and sound promoted neuronal communication, calmed immune cells, and slowed brain atrophy, but cognitive benefit remains unclear.
After news on “new data” they won’t see, three committee members argue against approval.
In therapy-like paradigm, suppressing ApoE4 in astrocytes toned down tauopathy. This assuaged microglia, neurodegeneration, and revived nest-building.
New research implicates IL-6 signaling and even Aβ42 itself as BACE targets, complicating efforts to resurrect BACE inhibitors at a low dose.
Alzforum encourages users to visit the Virtual Exhibit Hall, where companies showcase their newest initiatives, products, and services. We welcome F. Hoffmann-La Roche, joining our other exhibitors — Biogen, BioLegend, Abcam, BrainXell, and the Jackson Laboratory.
Can electric current spark better memory in people with mild cognitive impairment? Possibly, according to researchers—at least short-term. In a pilot study, people with MCI received transcranial alternating current stimulation (tACS), a low-intensity electric current therapy, set at a gamma frequency of 40 Hz. After a one-hour session, they recalled more words, matched more names to faces, and had improved cholinergic signaling compared to people who got sham treatment. Whether this was mediated by gamma entrainment will be tested in a larger trial.
Two presentations at the AD/PD 2021 conference appear to strengthen the proposed link between herpes simplex virus and Alzheimer’s disease. In a French study, herpes infection bumped up AD risk in ApoE4 carriers but not noncarriers. Damaged white matter and ever-so-slightly smaller hippocampi were discerned in infected people of all ApoE genotypes. In a German study, higher CSF herpes antibody titers tracked with CSF p-tau in people with mild AD.
If enhancing cognition with light and sound seems futuristic, then welcome to the future. Or so some scientists say. Results from four early stage clinical studies on mild Alzheimer’s disease were presented at the virtual AD/PD 2021 conference. The studies used two related approaches to modulate brain waves. Both reportedly synchronized neural firing in the gamma frequency range, harmonized neuronal connections, shifted the brain’s cytokine profile, and slowed brain atrophy. Memory and functional measures gave mixed results.
New in last 7 days
Latest Comments